{
    "symbol": "ALC",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-11 13:47:11",
    "content": " And that's obviously why we're spending a lot of time talking about Vivity and penetration, and trying to work a series of programs on the ground that actually engage surgeons in the process of the pre-op work that's required but also importantly the knowledge and use of Vivity, which I think at this point is one of the kind of no regret moves in ophthalmology. And I think as we think through this year, we expect to be back to kind of what I would loosely call normal growth rates plus a little bit, given that there's some pent-up demand out there."
}